Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Oculomotor Nerve Diseases in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
London Metropolitan University
Gynea Laboratorios SA
Nuseed Americas Inc.
Marealis AS
Universidad de Chile (UChile, Chile)
Washington State Attorney General's Office
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
Advanced Reconstructive Surgery Alliance
Hoffmann-La Roche
mHealth Impact Lab
Peijas Hospital
the Regional Direction of Clinical Research
Stefano Rizza
Pedro Rodrigues Genta
Center for HIV/AIDS Vaccine Immunology
WillowWood Global LLC
HMO Gesundheitsplan Basel, Switzerland
Hangzhou Neoantigen Therapeutics Co., Ltd.
delta medical promotions ag
IRCCS San Raffaele Roma
View Full List
Medical Conditions
ERYTHROCYTOSIS
Survivors of Childhood Cancer
Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
PURPURA
Midgut Carcinoid Tumor
CHD - Coronary Heart Disease
Hyperhidrosis Primary Focal Axilla
Urosepsis
Cervical Spondylotic Myelopathy
Tonsil Disease
Varicocele Grade III
Urinary System Stones
Hermansky Pudlak Syndrome
Flatulence
Apgar; 0-3 at 1 Minute
Hyperthyroid
Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission
Amniotic Fluid Leakage
Unrestricted Arm Movement
Charcot-Marie-Tooth Disease Type 2U (Diagnosis)
View Full List
Drug Interventions
Atorvastatin
Metronidazole
Rituxumab
Delamanid
Immediate-release nicotinamide (SAD)
Etoposide
RhGM-CSF
Active Comparator: TU2670 320mg
Neridronate
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Vincristine
Basiliximab
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Yohimbine hydrochloride
Silymarin (Silybum marianum)
Amivantamab
Ibrutinib
BIC/FTC/TAF
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Simvastatin
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gambia
Contract Research Organizations in Lebanon
Contract Research Organizations in Malaysia
Contract Research Organizations in Morocco
Contract Research Organizations in Netherlands
Contract Research Organizations in Pakistan
Contract Research Organizations in Poland
Contract Research Organizations in Slovakia
Contract Research Organizations in Ukraine
CRO list by country
CROs in Congo
SGS
All CROs in Congo
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe